Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Mar;53(3):198-208.
doi: 10.1097/FJC.0b013e31819b52d5.

Ceramide and mitochondria in ischemia/reperfusion

Affiliations
Review

Ceramide and mitochondria in ischemia/reperfusion

Sergei A Novgorodov et al. J Cardiovasc Pharmacol. 2009 Mar.

Abstract

A hallmark of tissue injury in various models of ischemia/reperfusion (IR) is mitochondrial dysfunction and the release of mitochondrial proapoptotic proteins leading to cell death. Although IR-induced mitochondrial injury has been extensively studied and key mitochondrial functions affected by IR are chiefly characterized, the nature of the molecule that causes loss of mitochondrial integrity and function remains obscure. It has become increasingly clear that ceramide, a membrane sphingolipid and a key mediator of cell stress responses, could play a critical role in IR-induced mitochondrial damage. Emerging data point to excessive ceramide accumulation in tissue and, specifically, in mitochondria after IR. Exogenously added to isolated mitochondria, ceramide could mimic some of the mitochondrial dysfunctions occurring in IR. The recent identification and characterization of major enzymes in ceramide synthesis is expected to contribute to the understanding of molecular mechanisms of ceramide involvement in mitochondrial damage in IR. This review will examine the experimental evidence supporting the important role of ceramide in mitochondrial dysfunction in IR to highlight potential targets for pharmacological manipulation of ceramide levels.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Biosynthesis of ceramide and its conversion into other bioactive sphingolipids
De novo ceramide synthesis begins with the conversion of serine and fatty acyl CoA into 3-ketosphinganine by serine palmitoyl transferase (SPT), then 3-ketosphinganine is converted into dihydrosphingosine. Myriocin is a potent inhibitor of SPT activity. (Dihydro) ceramide synthase (LASS/CerS) acylates dihydrosphingosine to form dihydroceramide, which is then reduced to ceramide by dihydroceramide desaturase. Ceramide is also produced by sphingomyelinases (SMases) through sphingomyelin (SM) degradation in sphingomyelinase pathway. Ceramidase converts ceramide into sphingosine, which is phosphorylated by sphingosine kinase (SK) to generate sphingosine-1-phosphate. Ceramide is phosphorylated by ceramide kinase (CK) yielding ceramide-1-phosphate (C1P). In the salvage or recycling pathway, complex sphingolipids are broken down to ceramide by β-glucosidase and then by ceramidase to sphingosine, which is re-acylated to ceramide by LASS/CerS. Fumonisin B1 inhibits LASS/CerS activity.
Figure 2
Figure 2. Ceramide modulates mitochondrial functions through direct and indirect mechanisms
A. Indirect modulation of mitochondrial functions by ceramide occurs through the change in the ratio of pro-apoptotic/anti-apoptotic proteins of Bcl-2 family at the outer mitochondrial membrane. B. Direct modulation of mitochondrial functions by ceramide include a) formation of ceramide channels permeable for cytochrome c in the outer mitochondrial membrane; b) potentiation of mitochondrial permeability transition pore opening (MPTP) in the inner membrane in the presence of Ca2+ or Bax (ceramide-induced Ca2+ release from the endoplasmic reticulum (ER) can contribute to the processes; c) potentiation of Bax insertion (activation) in to the outer membrane, d) inhibition of the respiratory chain (RC) with a subsequent increase in reactive oxygen species (ROS) formation.

Similar articles

Cited by

References

    1. Hannun YA, Luberto C. Ceramide in the eukaryotic stress response. Trends Cell Biol. 2000;10(2):73–80. - PubMed
    1. Colombaioni L, Garcia-Gil M. Sphingolipid metabolites in neural signalling and function. Brain Res Brain Res Rev. 2004;46(3):328–55. - PubMed
    1. Hannun YA, Obeid LM. The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem. 2002;277(29):25847–50. - PubMed
    1. Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol. 2008;9(2):139–50. - PubMed
    1. Kolesnick RN, Kronke M. Regulation of ceramide production and apoptosis. Annu Rev Physiol. 1998;60:643–65. - PubMed

Publication types

MeSH terms